Spontaneous reports of thrombocytopenia in association with quinine: Clinical attributes and timing related to regulatory action

Quinine has been marketed in the United States (U.S.) both over‐the‐counter (OTC) and by prescription for numerous purposes, including malaria and muscle spasms. In 1994 and 1995, the U.S. Food and Drug Administration (FDA) acted to limit the marketing of quinine based on the conclusion that no data...

Ausführliche Beschreibung